Looking at the COPD spectrum through "PRISm"

Affiliations

¹ Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
² Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada msafavi@mail.ubc.ca.

Free article

Editorial

Amin Adibi et al. Eur Respir J. 2020.

Free article

. 2020 Jan 2;55(1):1902217.

doi: 10.1183/13993003.02217-2019. Print 2020 Jan.

¹ Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
² Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada msafavi@mail.ubc.ca.

No abstract available

Conflict of interest statement

Conflict of interest: A. Adibi has nothing to disclose. Conflict of interest: M. Sadatsafavi has nothing to disclose.

Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
Wijnant SRA, De Roos E, Kavousi M, Stricker BH, Terzikhan N, Lahousse L, Brusselle GG. Wijnant SRA, et al. Eur Respir J. 2020 Jan 2;55(1):1901217. doi: 10.1183/13993003.01217-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31601717